Immuno Oncology Europe
Immuno Oncology Europe
Immuno-Oncology Summit Europe
地點:英國倫敦,Hilton Canary Wharf


Novel Approaches for Cancer   Immunomodulatory Approaches  Combination Immunotherapy


3月21日 18:30-21:30

Dinner SC1:
New Directions in Cancer Immunotherapy (癌免疫療法新方向)

Dinner SC2:
CAR T and TCR Manufacturing Challenges to Anticipate and Overcome: Focus on How, Where, and Cost Factors (CAR-T及TCR製造相關課題預測及克服:方法、場所、費用要因)

Featured Presenters

Roy BaynesRoy D. Baynes, M.D., Ph.D.
Senior Vice President and Head, Global Clinical Development, CMO, Merck Sharp & Dohme

Zelig EshharZelig Eshhar, Ph.D.
Chair, Cancer Immunotherapy, Research and Development, Sourasky Medical Center, Tel Aviv

David FeltquateDavid Feltquate, M.D., Ph.D.
Vice President, Oncology Development, Bristol-Myers Squibb

Dario NeriDario Neri, Ph.D.
Professor, Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich

Andy_SewellAndrew Sewell, Ph.D.
Professor, Institute of Infection & Immunity, Cardiff University School of Medicine

Robert WilkinsonRobert W. Wilkinson, Ph.D.
Director, Oncology Research, MedImmune Ltd.



承接上屆高峰會的成功經驗,Immuno-Oncology Summit Europe在2017年也將繼續舉行。本屆高峰會將跟2016年一樣,在倫敦的中心地帶舉行,是世界各國研究人員及業界相關人士不可錯過的重要活動。



"Very stimulatory meeting in an exciting field. Great mix of complementary presentations."

Kerry Chester, Ph.D., Professor, UCL Cancer Institute

"I believe you managed to collate an excellent mix of speakers spanning the most critical aspects of immune oncology, providing an informal forum for discussions between leaders in the field and new investigators coming from both academia and industry."

Björn Frendéus, Ph.D., Chief Scientific Officer, BioInvent International AB

"The content of the meeting was highly relevant and up to date."

Khaterech Ahmadi, Executive Director, MSD-Merck

"The meeting was ideal in terms of size and content. I really enjoyed the conference. It was very insightful and great quality of research was presented."

Sujiet Puthenveetil, Ph.D., Principal Scientist, Medicinal Chemistry, Pfizer, Inc.

Choose your language